Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
Phase 1
Active, not recruiting
- Conditions
- Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8Stage IIB Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8Unresectable Pancreatic Ductal Adenocarcinoma
- Interventions
- Other: Perflubutane MicrobubbleProcedure: Contrast-Enhanced UltrasoundOther: Quality-of-Life AssessmentProcedure: Computed TomographyProcedure: Magnetic Resonance Imaging
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2025-11-04
- Lead Sponsor
- Flemming Forsberg
- Target Recruit Count
- 120
- Registration Number
- NCT04821284
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇳🇴Haukeland University Hospital, Bergen, Norway
News
No news found